In this episode of Medsider Radio, we had a fun chat with Conor Cullinane, co-founder and CEO of Pirouette Medical. The company, founded by three rocket scientists, is developing a low-profile, disc-shaped injector designed to deliver medicines as easily as pushing a button.
Conor studied Aeronautical Engineering at Clarkson University and graduated with minors in Biomedical Engineering and Mathematics, followed by his PhD in Medical Engineering & Medical Physics at MIT and Harvard Medical School. He is also a mentor for Field X at Harvard Business School and a NASA Space Technology Research Fellow.
In this interview, Conor shares learnings from launching a community fundraising round, insights on selective innovation, identifying different value propositions for diverse stakeholders, and building strong investor relationships.
Before we dive into the discussion, I wanted to mention a few things:
First, if you’re into learning from medical device and health technology founders and CEOs, and want to know when new interviews are live, head over to Medsider.com and sign up for our free newsletter.
Second, if you want to peek behind the curtain of the world's most successful startups, you should consider a Medsider premium membership. You’ll learn the strategies and tactics that founders and CEOs use to build and grow companies like Silk Road Medical, AliveCor, Shockwave Medical, and hundreds more!
We recently introduced some fantastic additions exclusively for Medsider premium members, including playbooks, which are curated collections of our top Medsider interviews on key topics like capital fundraising and risk mitigation, and a curated investor database to help you discover your next medical device or health technology investor!
In addition to the entire back catalog of Medsider interviews over the past decade, premium members also get a copy of every volume of Medsider Mentors at no additional cost, including the latest Medsider Mentors Volume VI. If you’re interested, go to medsider.com/subscribe to learn more.
Lastly, if you'd rather read than listen, here's a link to the full interview with Conor Cullinane.